In last trading session, Esperion Therapeutics Inc (NASDAQ:ESPR) saw 1.57 million shares changing hands with its beta currently measuring 1.04. Company’s recent per share price
In last trading session, Esperion Therapeutics Inc (NASDAQ:ESPR) saw 2.03 million shares changing hands with its beta currently measuring 1.04. Company’s recent per share price
During the recent session, Esperion Therapeutics Inc (NASDAQ:ESPR)’s traded shares were 0.58 million, with the beta value of the company hitting 1.04. At the last
In the last trading session, 4.11 million shares of the Esperion Therapeutics Inc (NASDAQ:ESPR) were traded, and its beta was 1.04. Most recently the company’s
In the last trading session, 1.9 million shares of the Esperion Therapeutics Inc (NASDAQ:ESPR) were traded, and its beta was 1.03. Most recently the company’s
In the latest trading session, 0.81 million Esperion Therapeutics Inc (NASDAQ:ESPR) shares changed hands as the company’s beta touched 1.01. With the company’s most recent
In recent trading session, Esperion Therapeutics Inc (NASDAQ:ESPR) saw 3.1 million shares changing hands at last check today with its beta currently measuring 1.00. Company’s
Esperion Therapeutics Inc (NASDAQ:ESPR) has a beta value of 1.02 and has seen 2.92 million shares traded in the last trading session. The company, currently
Esperion Therapeutics Inc (NASDAQ:ESPR) has a beta value of 1.02 and has seen 0.67 million shares traded in the recent trading session. The ESPR stock
During the recent session, Esperion Therapeutics Inc (NASDAQ:ESPR)’s traded shares were 1.56 million, with the beta value of the company hitting 1.03. At the last
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
